Andrew Owen

48PUBLICATIONS
222CO-AUTHORS
PharmacogenomicsMedical virologyFoetal development and medicinePharmaceutical delivery technologiesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 04, 2026
The relationship between plasma favipiravir concentrations and clinical outcomes in COVID-19.

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|Apr 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation.

Moherndran Archary, Robert Bies, Osei Boateng

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Feb 18, 2026
Accelerating Generic Long-Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access.

Usman Arshad, Lobna Gaayeb, Henry Pertinez

|Jan 08, 2025
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters.

Megan Neary, Eduardo Gallardo-Toledo, Joanne Sharp

Pageof 8

Frequent Collaborators

12 joint publications

James Stewart

10 joint publications

Saye Khoo

10 joint publications

Rajith Kumar Reddy Rajoli

9 joint publications

Megan Neary